Condition: Pain, Chronic · Sponsor: Université de Sherbrooke
The primary objective of this study is to determine, in a healthcare setting, the effectiveness of actual tDCS in reducing pain compared with placebo tDCS. This is a multicenter randomized controlled trial with parallel groups (real tDCS vs. placebo) blinded to participants, assessors and tDCS providers. The real tDCS group will receive a daily 20-minute session of tDCS (current intensity = 2 mA), for 5 consecutive days, while the placebo tDCS group will receive an equivalent treatment, but the current will be stopped after the first 30 seconds. The study will take place in 5 rehabilitation clinics in 3 Quebec regions. One hundred and fifty (150) seniors aged 65 years or older with chronic (\> 6 months), moderate to severe musculoskeletal pain will be recruited (50 participants/region). Follow-ups will take place at 1 week and 3 months post-treatment. The primary dependent variable is pain intensity (numerical scale from 0 to 10). Secondary variables will be measured using standardized and validated questionnaires: 1) pain-related interferences (physical function, mood, quality of life) and 2) perception of post-TDCS changes. Neurophysiological measures (pain control pathways).
This description comes directly from the study's public registry record.
Marie-Philippe Harvey, Ph. D · 819 821-8000 · marie.philippe.harvey@usherbrooke.ca
Guillaume Léonard, Ph. D · 819-780-2220 · guillaume.leonard2@usherbrooke.ca
Always discuss trial participation with your own doctor first.
| Institut universitaire sur la réadaptation en déficience physique de Montréal (IURDPM) | Montreal, Quebec, Canada | Recruiting |
| CHU de Québec-Université Laval | Québec, Quebec, Canada | Recruiting |
| Centre de recherche sur le vieillissement (CdRV) | Sherbrooke, Quebec, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05617027